Search tips
Search criteria 


Logo of gutGutView this articleSubmit a manuscriptReceive email alertsContact usBMJ
Gut. 1993; 34(2 Suppl): S144–S145.
PMCID: PMC1374045

Interferon alfa-2b in mixed cryoglobulinaemia: a controlled crossover trial.


To confirm the positive results of a preliminary trial, 26 patients with mixed cryoglobulinaemia were enrolled in a controlled, randomised, crossover trial with interferon alfa-2b. A significant improvement was seen in the purpura score and alanine aminotransferase activities during six months' treatment, and was associated with a significant decrease in cryocrit and a returning to normal of the lymphocyte CD4/CD8 ratio (in eight of nine patients). No significant variations were seen during the six month period without interferon. Only six patients withdrew from treatment, three because of side effects and three because of poor compliance.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (231K), or click on a page image below to browse page by page.

Articles from Gut are provided here courtesy of BMJ Group